Novel endothall-containing platinum(IV) complexes: Synthesis, characterization, and cytotoxic activity

Chemistry and Biodiversity

Volumn 5, Issue 10, 2008, Pages 2160-2170

  Reithofer, Michael R ^a   Valiahdi, Seied M ^a   Galanski, Markus ^a   Jakupec, Michael A ^a   Arion, Vladimir B ^a   Keppler, Bernhard K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CARBOXY 7 EXO OXABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATO)DICHLORIDO(ETHANE 1,2 DIAMINE)PLATINUM; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 7 OXABICYCLO[2.2.1]HEPTANE 2,3 DICARBOXYLIC ACID DISODIUM; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC METAL COMPLEX; CANTHARIDIN; CISPLATIN; DIAMMINEBIS( 3 CARBOXY 7EXO OXABICYCLO[2.2.1]HEPTANE 2 CARBOXYLATO)DICHLORIDOPLATINUM; PLATINUM COMPLEX; UNCLASSIFIED DRUG; (3 CARBOXYOXABICYCLO(2.2.1)HEPTANE 2 CARBOXYLATO)DICHLORIDO(ETHANE 1,2 DIAMINE)PLATINUM(IV); (3-CARBOXYOXABICYCLO(2.2.1)HEPTANE-2-CARBOXYLATO)DICHLORIDO(ETHANE-1,2-DIAMINE)PLATINUM(IV); DEMETHYLCANTHARIDIN; DIAMMINEBIS(3 CARBOXYOXABICYCLO(2.2.1)HEPTANE 2 CARBOXYLATO)DICHLORIDOPLATINUM(IV); DIAMMINEBIS(3-CARBOXYOXABICYCLO(2.2.1)HEPTANE-2-CARBOXYLATO)DICHLORIDOPLATINUM(IV); DICARBOXYLIC ACID; DRUG DERIVATIVE; PLATINUM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CARBOXYLATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; MASS SPECTROMETRY; NITROGEN NUCLEAR MAGNETIC RESONANCE; OSTEOSARCOMA; OVARY CARCINOMA; PROTON NUCLEAR MAGNETIC RESONANCE; UTERINE CERVIX CARCINOMA; X RAY DIFFRACTION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; SYNTHESIS; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; CANTHARIDIN; CELL LINE, TUMOR; CELL SURVIVAL; CRYSTALLOGRAPHY, X-RAY; DICARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; ORGANOPLATINUM COMPOUNDS; PLATINUM;

EID: 58149347512     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200890197     Document Type: Article

References (37)

1. M. A. Jakupec, M. Galanski, B. K. Keppler, Rev. Physiol. Biochem. Pharmacol. 2003, 146, 1.
2. P. J. O'Dwyer, J. P. Stevenson, S. W. Johnson, Drugs 2000, 59 Suppl. 4, 19.
3. M. Galanski, M. A. Jakupec, B. K. Keppler, Curr. Med. Chem. 2005, 12, 2075.
4. R. J. Schilder, F. P. LaCreta, R. P. Perez, S. W. Johnson, J. M. Brennan, A. Rogatko, S. Nash, C. McAleer, T. C. Hamilton, D. Roby, R. C. Young, R. F. Ozols, P. J. O'Dwyer, Cancer Res. 1994, 54, 709.
5. M. D. Hall, T. W. Hambley, Coord. Chem. Rev. 2002, 232, 49.
6. M. D. Hall, R. C. Dolman, T. W. Hambley, in 'Metal Ions in Biological Systems, Eds. A. Sigel, H. Sigel, Vol. 42, 2004, pp. 297-322.
7. S. Choi, C. Filotto, M. Bisanzo, S. Delaney, D. Lagasee, J. L. Whitworth, A. Jusko, C. Li, N. A. Wood, J. Willingham, A. Schwenker, K. Spaulding, Inorg. Chem. 1998, 37, 2500.
8. C. M. Giandomenico, M. J. Abrams, B. A. Murrer, J. F. Vollano, M. I. Rheinheimer, S. B. Wyer, G. E. Bossard, J. D. Higgins III, Inorg. Chem. 1995, 34, 1015.
9. M. Galanski, B. K. Keppler, Met.-Based Drugs 1995, 2, 57.
10. M. Galanski, B. K. Keppler, Inorg. Chem. 1996, 35, 1709.
11. M. Galanski, B. K. Keppler, Inorg. Chim. Acta 1997, 265, 271.
12. W. H. Ang, I. Khalaila, C. S. Allardyce, L. Juillerat-Jeanneret, P. J. Dyson, J. Am. Chem. Soc. 2005, 127, 1382.
13. C. N. Sternberg, P. Whelan, J. Hetherington, B. Paluchowska, P. H. T. J. Slee, K. Vekemans, P. van Erps, C. Theodore, O. Koriakine, T. Oliver, D. Lebwohl, M. Debois, A. Zurlo, L. Collette, Oncology, 2005, 68, 2.
14. A. Kozubík, V. Horváth, L. Švihálková-Šindlerová, K. Souček, J. Hofmanová, P. Sova, A. Kroutil, F. Žák, A. Mistr, J. Turánek, Biochem. Pharmacol. 2005, 69, 373.
15. Y.-P. Ho, S. C. F. Au-Yeung, K. K. W. To, Med. Res. Rev. 2003, 23, 633.
16. Y. M. Li, J. E. Casida, Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11867.
17. M. Sodeoka, Y. Baba, S. Kobayashi, N. Hirukawa, Bioorg. Med. Chem. Lett. 1997, 7, 1833.
18. G.-S. Wang, J. Ethnopharmacol. 1989, 26, 147.
19. S. Yi, J. Wass, P. Vincent, H. Iland, Leuk. Res. 1991, 15, 883.
20. Y.-P. Ho, K. K. W. To, S. C. F. Au-Yeung, X. Wang, G. Lin, X. Han, J. Med. Chem. 2001, 44, 2065.
21. A. Alvarez-Valdés, J. M. Pérez, I. López-Solera, R. Lannegrand, J. M. Continente, P. Amo-Ochoa, M. J. Camazó n, X. Solans, M. Font-Bardía, C. Navarro-Ranninger, J. Med. Chem. 2002, 45, 1835.
22. K. R. Barnes, A. Kutikov, S. J. Lippard, Chem. Biol. 2004, 11, 557.
23. W. H. Ang, S. Pilet, R. Scopelliti, F. Bussy, L. Juillerat-Jeanneret, P. J. Dyson, J. Med. Chem. 2005, 48, 8060.
24. M. Reithofer, M. Galanski, A. Roller, B. K. Keppler, Eur. J. Inorg. Chem. 2006, 2612.
25. M. R. Reithofer, S. M. Valiahdi, M. A. Jakupec, V. B. Arion, A. Egger, M. Galanski, B. K. Keppler, J. Med. Chem. 2007, 50, 6692.
26. CCDC database V5.28, November 2006.
27. C. H. L. Kennard, G. Z. Smith, Z. Krystallogr. 1999, 188, 63.
28. U. Baumeister, H. Hartung, R. Kaplonek, Acta Crystallogr., Sect. C 1999, 55, 715.
29. G. Smith, D. E. Lynch, C. H. L. Kennard, T. C. W. Mak, Polyhedron 1991, 10, 1569.
30. Y.-H. Wang, Z.-X. Huang, G. Wu, Polyhedron 1997, 16, 57.
31. E. J. Bulten, F. Verbeek, U. S. Patent 4482569, 1984.
32. S. C. Dhara, Ind. J. Chem. 1970, 8, 193.
33. SAINT-Plus (Version 7.06a) and APEX2. Bruker-Nonius AXS Inc., 2004, Madison, Wisconsin, USA.
34. G. M. Sheldrick, SHELXS-97, Program for Crystal Structure Solution; University Göttingen, Göttingen, 1997.
35. G. M. Sheldrick, SHELXL-97, Program for Crystal Structure Refinement; University Göttingen, Göttingen, 1997.
36. G. K. Johnson, Report ORNL-5138, Oak Ridge National Laboratory, Oak Ridge, TN, 1976.
37. International Tables for X-ray Crystallography, Kluwer Academic Press, Dodrecht, The Netherlands, 1992, Vol. C, Tables 4.2.6.8 and 6.1.1.4.